Significance of macrolide resistance in Streptococcus pneumoniae.
Nuermberger
Eric L
EL
Bishai
William R
WR
D000368:Aged; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000493:pharmacokinetics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D008780:Methyltransferases / Q000235:genetics; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000235:genetics; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D018942:Macrolides; D019980:Amoxicillin-Potassium Clavulanate Combination; D008780:Methyltransferases; C035181:rRNA (adenosine-O-2'-)methyltransferase